"HARMFUL HERBS" REVIEW BY U.N.-SPONSORED EXPERT PANEL suggested in a draft report of the Codex Committee on Nutrition and Foods for Special Dietary Uses Oct. 7-11 meeting in Bonn, Germany. Asked by the Codex Executive Committee to consider the implications of a Canadian delegation paper addressing "potentially harmful herbs and botanical preparations sold as foods," the nutrition/special dietary uses committee determined that the group lacks the necessary experience to deal with the issue. The Canadian paper suggested that lists of "positive" and "negative" botanical ingredients be developed.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
The US MFN executive order is the latest in a series of concerning US developments that are contributing to uncertainty for the European pharmaceutical industry, according to France Biotech’s vice president, Alexandre Regniault.
Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.
At this year’s DIA China meeting, the national regulator updated its policy focus areas for this year, including clinical trial data protection and pilot projects to shorten IND approval times.
